Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Since our first report showing that the phenotype of
tyrosinase
-negative or type IA oculocutaneous albinism (OCA) is a consequence of a mutation in the
tyrosinase
gene (Tomita et al., Biochem. Biophys. Res. Commun., 164:990-996, 1989), a number of mutations were found in the
tyrosinase
gene of OCA patients. However, to establish the molecular basis of OCA in each patient, we must carry out several important experiments as summarized here. First, we should confirm that the cloned or amplified genomic DNA segments are not derived from the
pseudogene
or related gene. It should be noted that the putative
tyrosinase
pseudogene
contains the sequence almost identical to exons 4 and 5, including their exon/intron boundaries of the authentic
tyrosinase
gene. Thus, the mutations, detected in exon 4 or 5 amplified from genomic DNA, must be carefully analyzed to exclude a possibility that the mutation is located in the
pseudogene
. Second, it is of significance to confirm the promoter activity of the patients'
tyrosinase
gene. Accordingly, we established the cell-free transcription system derived from melanoma cells where the cloned
tyrosinase
gene is faithfully transcribed. Finally, transient expression assay of mutant
tyrosinase
is invaluable to conclude that OCA phenotypes are associated with the mutant
tyrosinase
alleles. I also discuss the implications of a cluster of mutation sites in exon 1 coding for the amino-terminus of
tyrosinase
.
...
PMID:Mutations of the tyrosinase gene in oculocutaneous albinism. 129 10
We have cloned and sequenced the putative human
tyrosinase
pseudogene
, which shares more than 98% nucleotide homology with exon 4 and exon 5 of the human
tyrosinase
gene including their flanking introns. Because of such a high homology, both the
tyrosinase
gene and its
pseudogene
could be amplified from genomic DNA by polymerase chain reaction. The nucleotide sequences presented thus enable us to discriminate the
tyrosinase
gene from its related sequences and are invaluable for a gene diagnosis of oculocutaneous albinism.
...
PMID:Nucleotide sequence of the putative human tyrosinase pseudogene. 190 58